5 Results for "

conditioned place preferences (CPPs)

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "conditioned place preferences (CPPs)" in MCE Product Catalog:

Cat. No.: HY-116181
CAS No.: 1221408-42-9
Purity:  98.62%
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

YQA14 is a high affinity dopamine D3 receptor antagonist. YQA14 is anti-opioid addiction agent. YQA14 inhibits Morphine/Cocaine-induced conditioned place preference (CPP) in animals .
loading...
    loading...
Cat. No.: HY-123889
CAS No.: 1982347-43-2
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

VK4-116 (Compound 19) is a selective Dopamine D3 receptor (D3R) antagonist with a Ki of 6.84 nM.VK4-116 significantly inhibits Oxycodone-induced hyperlocomotion and locomotor sensitization in mouse models. VK4-116 with pretreatment also inhibits the acquisition of Oxycodone-induced conditioned place preference (CPP) in rat models .
loading...
    loading...
Cat. No.: HY-111280
CAS No.: 854924-64-4
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

ST 198 is an orally active D3R antagonist. ST 198 can block the expression of nicotine-induced CPP at doses selective for D3R. ST 198 can be used for the research of neurological disease .
loading...
    loading...
Cat. No.: HY-W1025152
CAS No.: 760947-97-5
CPP-115 hydrochloride is an orally active, selective GABA-AT inhibitor with a Ki value of 9.7 μM. CPP-115 hydrochloride blocks GABA degradation and increases GABA levels in the brain. CPP-115 hydrochloride does not bind to GABA transporters, does not displace GABA from GABAA/GABAB receptors, and does not act as an agonist/antagonist of GABAC receptors. CPP-115 hydrochloride reduces cocaine-induced dopamine release, blocks cocaine-induced conditioned place preference, and suppresses seizure activity in a rat model of infantile spasms. CPP-115 hydrochloride can be used in research related to infantile spasms and epilepsy .
loading...
    loading...
Cat. No.: HY-179324
CAS No.: 1451412-34-2
Research Areas:  

Neurological Disease

Orexin receptor antagonist 6 (Compound 72) is a selective orexin 1 receptor (OX1) antagonist with a Ke of 8.5 nM and > 1180-fold selectivity for OX2. Orexin receptor antagonist 6 does not produce its own conditioned place preference (CPP) or aversive effects, and can inhibit the formation of CPP induced by psychoactive substances. Orexin receptor antagonist 6 can be used for research of neurological disease .
loading...
    loading...